Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |